NCT03568799

4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

[18F] 4-L-Fluoroglutamine (2S,4R) PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial studies positron emission tomography (PET) imaging utilizing 18F-(2S,4R)4-fluoroglutamine, a glutamic acid derivative, to image patients with Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules. \[18F\]Fluoroglutamine PET may provide additional information that help diagnose lung cancer.

Conditions

• Lung Cancer
• Solitary Pulmonary Nodule
• Cigarette Smoking Behavior

Interventions

Type	Name	Description
RADIATION	18F-(2S,4R)4-fluoroglutamine	Undergo 18F-(2S,4R)4-fluoroglutamine PET/CT

Timeline

• Start date: 2017-06-23
• Primary completion: 2019-12-31
• Completion: 2019-12-31
• First posted: 2018-06-26
• Last updated: 2018-10-19

Locations

1 site across 1 country: China